Floatz logo

Therapeutic Asset Ratings

9,920 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Propofol
Circadian Rhythm Sleep Disorder
Nyree PennP1CC (43)
prt7732
Gastric Squamous Cell Carcinoma
Prelude TherapeuticsP1CC (43)
prt7732
Gastroesophageal Junction Adenocarcinoma
Prelude TherapeuticsP1CC (43)
prt7732
Non-Small Cell Lung Carcinoma
Prelude TherapeuticsP1CC (43)
PS13
Long COVID-19
National Institute of Mental Health (NIMH)P1CC (43)
PS13
Cognitive Disorder
National Institute of Mental Health (NIMH)P1CC (43)
psb202
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)P1CC (43)
psb202
MALT Lymphoma
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)P1CC (43)
psb202
B-Cell Non-Hodgkin Lymphoma
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)P1CC (43)
Ptm-101
Pancreatic Adenocarcinoma
PanTher TherapeuticsP1CC (43)
Pyruvate
Human Papillomavirus-Related Squamous Cell Carcinoma
Pamela MunsterP1CC (43)
Pyruvate
PIK3CA-Related Overgrowth Spectrum
Pamela MunsterP1CC (43)
Pyruvate
Primary Central Nervous System Lymphoma
James RubensteinP1CC (43)
Pyruvate
Subarachnoid Hemorrhage
University of Maryland, BaltimoreP1CC (43)
Pyrvinium
Pancreatic Ductal Adenocarcinoma
Thomas Jefferson UniversityP1CC (43)
Pyrvinium
Malignant Pancreatic Neoplasm
Thomas Jefferson UniversityP1CC (43)
Pyrvinium
Pancreatic Adenocarcinoma
Thomas Jefferson UniversityP1CC (43)
q702
Acute Myeloid Leukemia
M.D. Anderson Cancer CenterP1CC (43)
q702
Histiocytic Sarcoma
Mayo ClinicP1CC (43)
q702
Malignant Histiocytosis
Mayo ClinicP1CC (43)
q702
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Mayo ClinicP1CC (43)
q702
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Mayo ClinicP1CC (43)
q702
CD4+/CD56+ Hematodermic Neoplasm
Mayo ClinicP1CC (43)
q702
B-Cell Chronic Lymphocytic Leukemia
Mayo ClinicP1CC (43)
q702
Chronic Myelomonocytic Leukemia
Mayo ClinicP1CC (43)
Showing 3976 to 4000 of 9,920 assets
PreviousPage 160 of 397Next